My bookmarksSign up free

Commission Regulation (EC) No 983/2009 ANNEX II

Commission Regulation (EC) No 983/2009 ANNEX II

ANNEX IISupplementary provisions

ANNEX II REJECTED HEALTH CLAIMS Application – Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 14(1)(a) health claim referring to reduction of disease risk NeOpuntia® NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol EFSA-Q-2008-214 Article 14(1)(a) health claim referring to reduction of disease risk Lactobacillus helveticus fermented Evolus®low-fat milk products Evolus® reduces arterial stiffness EFSA-Q-2008-218 Article 14(1)(b) health claim referring to children’s development and health regulat®.pro.kid IMMUN regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth EFSA-Q-2008-082 Article 14(1)(b) health claim referring to children’s development and health Dairy products Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence EFSA-Q-2008-110 Article 14(1)(b) health claim referring to children’s development and health Dairy products Dairy foods (milk & cheese) promote dental health in children EFSA-Q-2008-112 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) DHA and ARA support neural development of the brain and eyes EFSA-Q-2008-120 Article 14(1)(b) health claim referring to children’s development and health regulat®.pro.kid BRAIN regulat®.pro.kid BRAIN contributes to mental and cognitive development of children EFSA-Q-2008-083 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Calming EFSA-Q-2008-091 and EFSA-Q-2008-096 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Provide serenity and room for a beneficial development of the child EFSA-Q-2008-092 and EFSA-Q-2008-097 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Help to support vision EFSA-Q-2008-095 and EFSA-Q-2008-100 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Help to support mental development EFSA-Q-2008-098 and EFSA-Q-2008-104 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Help to promote concentration EFSA-Q-2008-094 and EFSA-Q-2008-099 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Helps to promote the thinking capacity EFSA-Q-2008-093 and EFSA-Q-2008-101 Article 14(1)(b) health claim referring to children’s development and health Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) Help to support the learning ability EFSA-Q-2008-102 and EFSA-Q-2008-103

Read the full instrument →

Other provisions in Commission Regulation (EC) No 983/2009

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX II of Commission Regulation (EC) No 983/2009 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next